Management of hepatic metastases from colorectal cancer
- PMID: 20011304
- PMCID: PMC2780092
- DOI: 10.1055/s-2005-916282
Management of hepatic metastases from colorectal cancer
Abstract
The majority of hepatic metastases in the United States occur in patients with a primary colorectal malignancy. Advances in technology combined with increasing surgeon experience have broadened the treatment options available for hepatic metastases from colorectal cancer. Surgical resection is the most effective therapy for metastatic colorectal cancer isolated to the liver. The aim of this article is to discuss the role of locally aggressive treatment options including resection, ablation, and regional chemotherapy in the management of patients with metastases from colorectal cancer.
Keywords: Hepatic metastases; colorectal cancer; hepatic ablation; hepatic resection.
Figures
Similar articles
-
Colorectal hepatic metastases: resection, local ablation, and hepatic artery infusion pump are associated with prolonged survival.Arch Surg. 2001 Mar;136(3):318-23. doi: 10.1001/archsurg.136.3.318. Arch Surg. 2001. PMID: 11231853
-
An update and our experience with metastatic liver disease.Hepatogastroenterology. 2007 Dec;54(80):2232-9. Hepatogastroenterology. 2007. PMID: 18265640
-
[Diagnosis and treatment of colorectal liver metastases - workflow].Zentralbl Chir. 2008 Jun;133(3):267-84. doi: 10.1055/s-2008-1076796. Zentralbl Chir. 2008. PMID: 18563694 Review. German.
-
Surgical treatment of hepatic metastases from colorectal cancer.World J Gastrointest Oncol. 2011 Jan 15;3(1):1-9. doi: 10.4251/wjgo.v3.i1.1. World J Gastrointest Oncol. 2011. PMID: 21267397 Free PMC article.
-
Modern multimodality approach to hepatic colorectal metastases: solutions and controversies.Surg Oncol. 2007 Jul;16(1):71-83. doi: 10.1016/j.suronc.2007.05.001. Epub 2007 May 29. Surg Oncol. 2007. PMID: 17532622 Review.
Cited by
-
Epidemiology of Stage IV Colorectal Cancer: Trends in the Incidence, Prevalence, Age Distribution, and Impact on Life Span.Clin Colon Rectal Surg. 2023 Mar 15;37(2):57-61. doi: 10.1055/s-0043-1761447. eCollection 2024 Mar. Clin Colon Rectal Surg. 2023. PMID: 38322602 Free PMC article. Review.
-
Targeting Cancer by Using Nanoparticles to Modulate RHO GTPase Signaling.Adv Exp Med Biol. 2022;1357:115-127. doi: 10.1007/978-3-030-88071-2_5. Adv Exp Med Biol. 2022. PMID: 35583642
-
Pre-operative prediction of histopathological growth patterns of colorectal cancer liver metastasis using MRI-based radiomic models.Abdom Radiol (NY). 2024 Dec;49(12):4239-4248. doi: 10.1007/s00261-024-04290-z. Epub 2024 Jul 29. Abdom Radiol (NY). 2024. PMID: 39069557
-
Statins exhibit anti-tumor potential by modulating Wnt/β-catenin signaling in colorectal cancer.Oncotarget. 2025 Jul 21;16:562-581. doi: 10.18632/oncotarget.28755. Oncotarget. 2025. PMID: 40689929 Free PMC article.
-
The S100P/RAGE signaling pathway regulates expression of microRNA-21 in colon cancer cells.FEBS Lett. 2015 Aug 19;589(18):2388-93. doi: 10.1016/j.febslet.2015.07.010. Epub 2015 Jul 17. FEBS Lett. 2015. PMID: 26193421 Free PMC article.
References
-
- Jemal A, Thomas A, Murray T, et al. Cancer statistics. CA Cancer J Clin. 2002;52:23–47. - PubMed
-
- Bengmark S, Hafstrom L. The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy. Cancer. 1969;23:198–202. - PubMed
-
- Cady B, Monson D, Swinton N. Survival of patients after colonic resection for carcinoma with simultaneous liver metastases. Surg Gynecol Obstet. 1970;131:697–700. - PubMed
-
- Scoggins C, Meszoely I, Blanke C, et al. Nonoperative management of primary colorectal cancer in patients with stage IV disease. Ann Surg Oncol. 1999;6:651–657. - PubMed
-
- Ohlsson B, Tranberg K, Lundstedt C, et al. Detection of hepatic metastases in colorectal cancer: a prospective study of laboratory and imaging methods. Eur J Surg. 1993;159:275–281. - PubMed